Wen-Hsiang Wen, MD, PhD - Caris Life Sciences

Wen-Hsiang Wen, MD, PhD
Molecular Oncologic Pathologist
E D U C AT I O N
1999 Ph.D. Keck School of Medicine, University of Southern California
1991 M.D. Kaohsiung Medical University, Kaohsiung, Taiwan
P O S T D O C T O R A L T R A I N I N G
2008-2009 Fellow in Molecular Genetic Pathology
University of Pittsburgh
2004-2008 Residency in Anatomic and Clinical Pathology
Hartford Hospital
C E R T I F I C AT I O N
Anatomic and Clinical Pathology, American Board of Pathology
P R O F E S S I O N A L S O C I E T I E S
Association for Molecular Pathology
College of American Pathologists
American Society for Clinical Pathology
United States and Canadian Academy of Pathology

C A R I S T A R G E T N O W
S E L E C T P U B L I C AT I O N S
Wen WH, Bernstein L, Press MF. Assessment of p53 mutations in
tamoxifen-associated and spontaneous endometrial cancers. (in
preparation).
Wen W-H, Press MF. Identification of TP53 mutations in
human cancers using oligonucleotide microarrays. Methods in
Molecular Medicine 97: 323-335, 2004. http://www.ncbi.nlm.
nih.gov/pubmed/15064503
Reles A, Wen WH, Gee C, Runnebaum IB, Schmider A, Jones LA,
El-Naggar A, Minguillon C, Reich O, Kreienberg R, Lichtenegger
W, Press MF. Correlation of p53 mutations with resistance to
platinum-based chemotherapy and shortened survival in ovarian
cancer. Clinical Cancer Research 7: 2984-2997, 2001. http://
www.ncbi.nlm.nih.gov/pubmed/11595686
Lukas J, Gao D-Q, Keshmeshian M, Wen W-H, Wei D, Rosenberg
S, Press MF. Alternative and aberrant messenger RNA splicing
of the mdm2 oncogene in invasive breast cancer. Cancer
Research 61: 3212-3219, 2001. http://www.ncbi.nlm.nih.gov/
pubmed/11306511
Wen W-H, Reles A, Runnebaum I, Sullivan-Halley J, Bernstein
L, Jones LA, Felix JC, Kreienberg R, El-Naggar A, Press MF.
p53 mutations and expression in ovarian cancers: Correlation
with overall survival. International Journal of Gynecological
Pathology 18: 29-41, 1999. http://www.ncbi.nlm.nih.gov/
pubmed/9891239
Wang-Gohrke S, Hees S, Pochon A, Wen W-H, Reles A, Press MF,
Kreienberg R, Runnebaum IB. Genomic semiautomated cycle
sequencing as a sensitive screening technique for p53 mutations
in frozen tumor samples. Oncology Reports 5: 65-68, 1998.
http://www.ncbi.nlm.nih.gov/pubmed/9458295
Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen W-H, Felix J,
Jones LA, Hall FL, Press MF. WAF1/Cip gene polymorphism and
expression in carcinomas of the breast, ovary and endometrium.
American Journal of Pathology 150: 167-175, 1997. http://
www.ncbi.nlm.nih.gov/pubmed/9006333
Wen W-H, Bernstein L, Lescallett J, Barclay Y, Sullivan-Halley
J, White M, Press MF. Comparison of TP53 mutations identified
by oligonucleotide microarray and conventional DNA sequece
analysis. Cancer Research 60: 2716-2722, 2000. http://www.
ncbi.nlm.nih.gov/pubmed/10825146
To order Caris Target Now services or
to speak with a Caris Life Sciences representative, call
1 . 8 0 0 . 9 0 1 . 5 1 7 7
or visit us online at www.CarisTargetNow.com
© 2011 Caris Life Sciences, Inc. All rights reserved. TN0090 11.11